In non-small cell lung cancer (NSCLC) two lncRNAs have been found to exert oncogenic function interacting with EZH2 and LSD1: Linc01133, which regulates the transcription of KFL2, p21 and E-cadherin controlling cell proliferation, migration and invasion as well as apoptosis [88]; and FEZF1-AS that epigenetically represses the expression of E-cadherin enhancing EMT process [89]. The gene discussed is LINC01133; the disease is non-small cell lung carcinoma.